SPX4,122.47-17.59 -0.42%
DIA327.91-0.51 -0.16%
IXIC12,493.93-150.53 -1.19%

Taro Pharmaceutical Indus: Q1 Earnings Insights

Taro Pharmaceutical Indus (NYSE:TARO) reported its Q1 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · 07/27/2022 18:08

Taro Pharmaceutical Indus (NYSE:TARO) reported its Q1 earnings results on Wednesday, July 27, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Taro Pharmaceutical Indus missed estimated earnings by 56.47%, reporting an EPS of $0.37 versus an estimate of $0.85.

Revenue was up $9.55 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.15 which was followed by a 3.89% increase in the share price the next day.

Here's a look at Taro Pharmaceutical Indus's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.88 0.91 1.02 0.84
EPS Actual 0.73 0.70 0.66 1.09
Revenue Estimate 147.01M 142.22M 153.23M 137.23M
Revenue Actual 143.26M 139.00M 131.99M 147.11M

To track all earnings releases for Taro Pharmaceutical Indus VISIT THEIR EARNINGS CALENDAR HERE.

This article was generated by Benzinga's automated content engine and reviewed by an editor.